Literature DB >> 31332318

Limiting biomaterial fibrosis.

Ruud A Bank1.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2019        PMID： 31332318     DOI： 10.1038/s41563-019-0428-y

Source DB:  PubMed          Journal:  Nat Mater        ISSN： 1476-1122            Impact factor:   43.841


× No keyword cloud information.
  5 in total

1.  Improving hard metal implant and soft tissue integration by modulating the "inflammatory-fibrous complex" response.

Authors:  Peina Huang; Jieyun Xu; Lv Xie; Guangqi Gao; Shoucheng Chen; Zhuohong Gong; Xiaomei Lao; Zhengjie Shan; Jiamin Shi; Zhaocai Zhou; Zhuofan Chen; Yang Cao; Yan Wang; Zetao Chen
Journal:  Bioact Mater       Date:  2022-05-18

2.  Calcium-based nanomaterials and their interrelation with chitosan: optimization for pCRISPR delivery.

Authors:  Navid Rabiee; Mojtaba Bagherzadeh; Amir Mohammad Ghadiri; Mahsa Kiani; Sepideh Ahmadi; Vahid Jajarmi; Yousef Fatahi; Abdullah Aldhaher; Mohammadreza Tahriri; Thomas J Webster; Ebrahim Mostafavi
Journal:  J Nanostructure Chem       Date:  2021-09-22

Review 3.  Drug delivery carriers with therapeutic functions.

Authors:  Shuting S Cai; Tianyu Li; Tolulope Akinade; Yuefei Zhu; Kam W Leong
Journal:  Adv Drug Deliv Rev       Date:  2021-07-21       Impact factor: 17.873

4.  Microchannel-embedded implantable device with fibrosis suppression for prolonged controlled drug delivery.

Authors:  Han Bi Ji; Jae Young Hong; Cho Rim Kim; Chang Hee Min; Jae Hoon Han; Min Ji Kim; Se-Na Kim; Cheol Lee; Young Bin Choy
Journal:  Drug Deliv       Date:  2022-12       Impact factor: 6.419

5.  ZnAl nano layered double hydroxides for dual functional CRISPR/Cas9 delivery and enhanced green fluorescence protein biosensor.

Authors:  Navid Rabiee; Mojtaba Bagherzadeh; Amir Mohammad Ghadiri; Ghazal Salehi; Yousef Fatahi; Rassoul Dinarvand
Journal:  Sci Rep       Date:  2020-11-26       Impact factor: 4.379
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.